Opinion · 27 Jan 2025
Conference abstractPublished 3 Sep 2018
Is NAFLD benign disease?
Lifecare Hospital, UAE
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic liver disease in the world. NAFLD exhibits a histological spectrum, ranging from steatosis to the more aggressive necro-inflammatory form, non-alcoholic steatohepatitis to cirrhosis leading to Hepatocellular carcinoma. Ongoing clinical trials are focused on an array of disease mechanisms and reviewed here are how these treatments fit into the current paradigm of substrate overload lipotoxic liver injury. Emerging data suggests fibrosis, rather than NASH per se, to be the most important histological predictor of liver and non-liver related death. Nevertheless, only a small proportion of individuals develop cirrhosis, NAFLD has led to predictions that it will become a leading cause of end stage liver disease, Hepatocellular carcinoma (HCC), and indication for liver transplantation. HCC may arise in non-cirrhotic liver in the setting of NAFLD. The Metabolic syndrome and its components also play a key role in the histological progression of NAFLD, however other genetic and environmental factors may also influence the natural history. The importance of NAFLD in terms of overall survival extends beyond the liver where evtraintestinal manifestations like cardiovascular disease and malignancy represents additional important causes of death.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 30 Nov 2024
Trends, Mortality and Socioeconomic Inequalities in Pediatric Non-alcoholic Fatty Liver Disease (NAFLD) in the United States, 1998?2020
Perspective · 20 Nov 2024
Non-Alcoholic Fatty Liver Disease (NAFLD): Challenges and Innovations in Gastroenterology
Perspective · 29 Mar 2024
Therapeutic Innovations in Non-Alcoholic Fatty Liver Disease (NAFLD) and Advancements in Health Management
Research article · 29 Aug 2023
Thrombocytopenia in Non-Alcoholic Fatty Liver Disease (NAFLD)
More from this journal
The newest in Journal of Hepatology and Gastrointestinal disorders.
Conference abstract · 18 Nov 2025
Inflammatory bowel disease
Conference abstract · 18 Nov 2025
Health benefits of probiotic bacteria
Conference abstract · 18 Nov 2025
Comprehensive case study of periampullary carcinoma in a 70-year-old patient: Management, nursing interventions, and recovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Hepatology and Gastrointestinal disorders
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Mathew Vadukoot L”

